Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

299.82
-5.1400-1.69%
Volume:313.82K
Turnover:93.68M
Market Cap:14.31B
PE:-61.42
High:305.00
Open:305.00
Low:294.37
Close:304.96
52wk High:333.30
52wk Low:146.20
Shares:47.74M
Float Shares:47.20M
Volume Ratio:1.50
T/O Rate:0.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:5.04
PE(LYR):-102.95

Loading ...

Charles River Laboratories International, Inc. : Jefferies Raises Target Price to $340 from $305

THOMSON REUTERS
·
Sep 28

Charles River Laboratories's DAS Segment Faces Largest Margin Upside, RBC Says

MT Newswires Live
·
Sep 25

Charles River Labs is Maintained at Overweight by Barclays

Dow Jones
·
Sep 25

Charles River price target raised to $295 from $264 at Mizuho

TIPRANKS
·
Sep 25

Charles River Laboratories : Deutsche Bank Raises Target Price to $320 from $300

THOMSON REUTERS
·
Sep 25

Evercore ISI Adjusts PT on Charles River Laboratories International to $330 From $320, Maintains Outperform Rating

MT Newswires Live
·
Sep 25

Barclays Keeps Their Buy Rating on Charles River Labs (CRL)

TIPRANKS
·
Sep 25

US Research Roundup-Chevron, Exxon Mobil, GoDaddy

Reuters
·
Sep 25

Charles River Laboratories International, Inc. : Baird Raises Target Price to $334 from $291

THOMSON REUTERS
·
Sep 25

Charles River Laboratories International Inc. Stock Rises 6.2%, Outperforms Peers

Dow Jones
·
Sep 25

Charles River Laboratories International Inc Stock (CRL) Moved Up by 7.23% on Sep 24: Facts Behind the Movement

TradingKey
·
Sep 25

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Reuters
·
Sep 25

Movement Alert|Charles River Laboratories Rises 5.33% in Regular Trading, Reaffirms Full-Year Guidance at Upper End and Issues Mid-to-Long-Term Growth Targets

Market Focus
·
Sep 24

US Stocks on the MOVE-Charles River, Oracle, TD Synnex

Reuters
·
Sep 24

Charles River Rises on 2026 Forecast Update, Long-Term Targets

Reuters
·
Sep 24

Charles River Laboratories Shares Rise 5% After Co Sees FY REV Growth, Adj Profit Forecast at Upper End of Prior Guidance

THOMSON REUTERS
·
Sep 24

Charles River Laboratories Reaffirms Fiscal 2026 Guidance; Issues 2030 Growth Projections

MT Newswires Live
·
Sep 24

GUIDANCE: (CRL) Charles River Laboratories Expects 2026 Adjusted EPS at Upper End of $11.15 - $11.45, vs. FactSet Est of $11.33

MT Newswires Live
·
Sep 24

Charles River Sees 2026 Revenue, Non-GAAP EPS at Upper End of Prior Guidance Ranges

Reuters
·
Sep 24

Charles River Laboratories International, - 2030 Target for Organic Revenue Growth is 5%-7% Cagr 2027-2030

THOMSON REUTERS
·
Sep 24